DBVT Q1 2023 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$2M100.0% margin

Operating Income

-$21M-964.7% margin

Net Income

-$21M-937.1% margin

EPS (Diluted)

$-1.20

QoQ Revenue Growth

+268.3%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$233M

Total Liabilities

$54M

Stockholders' Equity

$179M

Cash & Equivalents

$192M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	-$5M	+145.6%
Operating Income	-$21M	-$19M	-9.8%
Net Income	-$21M	-$17M	-23.4%